Implications of the evolving knowledge of the genetic architecture of MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) has a strong heritable component, and genome-wide association cohort studies are highlighting the major genetic determinants of this condition. A meta-analysis of these databases has now enabled expansion of the list of the inherited variants that modulate the risk of MASLD. The identification of new MASLD risk loci is improving comprehension of disease pathogenesis and individual risk stratification, and also enabling the identification of novel therapeutic targets and disease subtypes that might ultimately lead to a precision medicine approach.

Automated summary

Metabolic dysfunction-associated steatotic liver disease (MASLD) has a strong heritable component, and new inherited variants that modulate the risk of MASLD have been identified. These findings improve our understanding of disease pathogenesis and enable the development of precision medicine approaches.